C Partners Holding’s Charles River Laboratories CRL Stock Holding History

C Partners Holding’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-963	Closed	-$130K	–	67
2018 Q3	$130K	Sell	963 -1,137	-54%	-$140K	0.05%	63
2018 Q2	$236K	Sell	2,100 -12	-0.6%	-$1.3K	0.09%	95
2018 Q1	$225K	Sell	2,112 -145	-6%	-$15.6K	0.09%	83
2017 Q4	$247K	Buy	+2,257	New	+$246K	0.1%	228

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

C Partners Holding's CRL Position: Q4 2018 in Review

C Partners Holding sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 963 shares — an estimated $130K sold.

C Partners Holding first reported a position in CRL in Q4 2017 and held it in 4 quarters. The position peaked at $247K in Q4 2017. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

C Partners Holding reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
C Partners Holding sold 963 Charles River Laboratories shares in Q4 2018, an estimated $130K.
C Partners Holding first reported a position in Charles River Laboratories in Q4 2017 and held it in 4 quarters.
C Partners Holding's Charles River Laboratories position peaked at $247K in Q4 2017.
407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.